Cognitive adaptation training combined with assertive community treatment: A randomised longitudinal trial

Schizophrenia Research

Volumn 135, Issue 1-3, 2012, Pages 105-111

  Hansen, Jens Peter ^a,b   Østergaard, Birte ^b   Nordentoft, Merete ^c   Hounsgaard, Lise ^b  

^a Mental Health Services   (Denmark)

^b UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Assertive community treatment; Memory disorders; Psychological adaptation; RCT

Indexed keywords

ADULT; ARTICLE; ASSERTIVE COMMUNITY TREATMENT; COGNITIVE ADAPTATION TRAINING; COGNITIVE THERAPY; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; FOLLOW UP; HOSPITAL READMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OUTCOME ASSESSMENT; OUTPATIENT; PARALLEL DESIGN; PRIORITY JOURNAL; PSYCHOLOGICAL RATING SCALE; PSYCHOSOCIAL CARE; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RELAPSE; SCHIZOPHRENIA; SOCIAL STATUS; SYMPTOM;

ADULT; COGNITIVE THERAPY; COMMUNITY MENTAL HEALTH SERVICES; CONFIDENCE INTERVALS; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; LONGITUDINAL STUDIES; MALE; OUTPATIENTS; PROPORTIONAL HAZARDS MODELS; PSYCHIATRIC STATUS RATING SCALES; QUALITY OF LIFE; REPRODUCIBILITY OF RESULTS; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; TIME FACTORS; YOUNG ADULT;

EID: 84857238960     PISSN: 09209964     EISSN: 15732509     Source Type: Journal    
DOI: 10.1016/j.schres.2011.12.014     Document Type: Article

References (28)

1. Altman D.G. Practical Statistics for Medical Research 1999, Chapman & Hall, London.
2. Andresen R., Caputi P., Oades L. Interrater reliability of the Camberwell Assessment of Need Short Appraisal Schedule. Aust. N. Z. J. Psychiatry 2000, 34:856-861.
3. Burns T. The rise and fall of assertive community treatment?. Int. Rev. Psychiatry 2010, 22:130-137.
4. Candilis P.J., Geppert C.M., Fletcher K.E., Lidz C.W., Appelbaum P.S. Willingness of subjects with thought disorder to participate in research. Schizophr. Bull. 2006, 32:159-165.
5. Candilis P.J., Fletcher K.E., Geppert C.M., Lidz C.W., Appelbaum P.S. A direct comparison of research decision-making capacity: schizophrenia/schizoaffective, medically ill, and non-ill subjects. Schizophr. Res. 2008, 99:350-358.
6. Green M.F., Kem R.S., Braff D.L., Mint J. Neurocognitive deficits and functional outcome in schizophrenia: are we measuring the "right stuff"?. Schizophr. Bull. 2000, 26:119-136.
7. Heaton R.K., Chelune G.J., Talley J.L., Kay G.G., Curtiss G. Wisconsin Card Sorting Test Manual: Revised and Expanded 1993, Psychological Assessment Resources Inc., Odessa, FL.
8. Hilsenroth M.J., Ackerman S.J., Blagys M.D., Baumann B.D., Baity M.R., Smith S.R., et al. Reliability and validity of DSM-IV axis V. Am. J. Psychiatry 2000, 157:1858-1863.
9. Johnson-Selfridge M., Zalewski C. Moderator variables of executive functioning in schizophrenia: meta-analytic findings. Schizophr. Bull. 2001, 27:305-316.
10. Kay S.R., Opler L.A., Lindenmayer J.P. Reliability and validity of the positive and negative syndrome scale for schizophrenics. Psychiatry Res. 1988, 23:99-110.
11. Kurtz M.M., Moberg P.J., Ragland J.D., Gur R.C., Gur R.E. Symptoms versus neurocognitive test performance as predictors of psychosocial status in schizophrenia: a 1- and 4-year prospective study. Schizophr. Bull. 2005, 31:167-174.
12. Marshall M., Lockwood A. Assertive community treatment for people with severe mental disorders. Cochrane Database Syst. Rev. 1998, 2.
13. McGrew J.H., Bond G.R., Dietzen L., Salyers M. Measuring the fidelity of implementation of a mental health program model. J. Consult. Clin. Psychol. 1994, 62:670-678.
14. Melle I., Friis S., Haahr U., Johannesen J.O., Larsen T.K., Opjordsmoen S., et al. Measuring quality of life in first-episode psychosis. Eur. Psychiatry 2005, 20:474-483.
15. Petersen L., Jeppesen P., Thorup A., Abel M., Oehlenschlaeger J., Christensen T.O., et al. A randomised multicentre trial of integrated versus standard treatment for patients with a first episode of psychotic illness. BMJ 2005, 1-7. 10.1136/bmj.38565.415000.E01.
16. Peuskens J., Demily C., Thibaut F. Treatment of cognitive dysfunction in schizophrenia. Clin. Ther. 2005, 27:25-37.
17. Pfammatter M., Junghan U.M., Brenner H.D. Efficacy of psychological therapy in schizophrenia: conclusions from meta-analyses. Schizophr. Bull. 2006, 32:64-80.
18. Rodriguez-Jimenez R., Aragues M., Jimenez-Arriero M.A., Ponce G., Martinez I., Hoenicka J., et al. Psychopathology and Wisconsin Card Sorting Test performance in male schizophrenic patients: influence of dual diagnosis. Psychopathology 2008, 41:58-64.
19. Schafer J.L., Graham J.W. Missing data: our view of the state of the art. Psychol. Methods 2002, 7:147-177.
20. Startup M., Jackson M.C., Bendix S. The concurrent validity of the global assessment of functioning (GAF). Br. J. Clin. Psychol. 2002, 6:417-422.
21. Thorup A., Petersen L., Jeppesen P., Ohlenschlaeger J., Christensen T., Krarup G., et al. Integrated treatment ameliorates negative symptoms in first episode psychosis-results from the Danish OPUS trial. Schizophr. Res. 2005, 79:95-105.
22. Thurston-Snoha B.J., Lewine R.R. Intact Wisconsin card sorting test performance: implications for the role of executive function in schizophrenia. Br. J. Clin. Psychol. 2007, 46:361-369.
23. Velligan D.I., Bow-Thomas C.C. Two case studies of cognitive adaptation training for outpatients with schizophrenia. Psychiatr. Serv. 2000, 51:25-30.
24. Velligan D.I., Mueller J., Wang M., Dicocco M., Diamond P.M., Maples N.J., et al. Use of environmental supports among patients with schizophrenia. Psychiatr. Serv. 2006, 57:219-224.
25. Velligan D.I., Diamond P.M., Maples N.J., Mintz J., Li X., Glahn D.C., et al. Comparing the efficacy of interventions that use environmental supports to improve outcomes in patients with schizophrenia. Schizophr. Res. 2008, 102:312-319.
26. Velligan D.I., Diamond P.M., Mintz J., Maples N., Li X., Zeber J., et al. The use of individually tailored environmental supports to improve medication adherence and outcomes in schizophrenia. Schizophr. Bull. 2008, 34:483-493.
27. Velligan D.I., Diamond P., Mueller J., Li X., Maples N., Wang M., et al. The short-term impact of generic versus individualized environmental supports on functional outcomes and target behaviors in schizophrenia. Psychiatry Res. 2009, 168:94-101.
28. Wing J.K., Beevor A.S., Curtis R.H., Park S.B., Hadden S., Burns A. Health of the nation outcome scales (HoNOS). Research and development. Br. J. Psychiatry 1998, 172:11-18.